ATTR Cardiac Amyloidosis in a Selected Population
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age50+
SponsorHelse Møre og Romsdal HF
About this trial
Patients operated for carpal tunnel syndrome (CTS) at Ålesund Hospital (200 patients) will have a biopsy to diagnose ATTR amyloidosis. Patients with positive biopsy will be examined to decide wether they have cardiac amyloidosis. All patients with positive biopsy will be followed closely for 10 years wit echocardiography an clinically.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Male > 50 years
Female > 60 years
operated CTS at Ålesund Hospital
Disqualifiers
not consented
do not speak Norwegian
secondary cause of CTS as traumatic or rheumatic
cannot be followed > 5 years due to other medical conditions
Trial population
Maximum 200 patients operated at Ålesund Hospital for CTS
Trial design
Design model
Case-only
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
Frequency of ATTR in CTS
Biopsy proven ATTR
Time frame
2 years2
Cardiac involvement in patients with biopsy proven ATTR
Scintigraphic and echocardiographic cardiac involvement possibly cMRI
Time frame
10 yearsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov